Clinical Outcome Following Early Decannulation of Severe Acquired Brain Injury Patients
1 other identifier
observational
60
1 country
1
Brief Summary
After severe acquired brain injury (SABI: severe traumatic brain injury, stroke, anoxic brain damage), up to 50-70% of patients are tracheostomized. The need to tracheostomize a patient is based on the prolonged inability to breathe and/or protect their airway sufficiently. This is usually done in an Intensive Care Unit (ICU). A tracheostomy is first removed when the patient's clinical conditions allow for it. The removal can be performed in many settings, a neurological rehabilitation unit being one of these. The overall objective of this study is to evaluate the safety of this earlier decannulation procedure in patients with SABI at our department as well as the effectiveness on functional ability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
November 17, 2023
CompletedFirst Posted
Study publicly available on registry
December 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedDecember 12, 2023
December 1, 2023
6 months
November 17, 2023
December 11, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Mortality at three months after hospital discharge
Rate of survival
Three months counted from hospital discharge
Mortality at twelve months after hospital discharge
Rate of survival
Twelve months counted from hospital discharge
Secondary Outcomes (4)
Rate of antibiotics prescribed to treat pneumonia after decannulation
Counted number of days from decannulation until discharge
Rate of re-cannulation of the tracheal tube after initial decannulation
Counted number of days from decannulation until discharge
Length of hospital stay
Counted number of days from admission to our department until discharge
Rate of hospital readmission at two and twelve months after discharge
At two and twelve months respectively counted from discharge
Study Arms (2)
SABI patients with a tracheal tube treated with the new decannulation procedure.
All adult SABI patients ≥ 18 years with a tracheal tube at admission to the Department of Brain Injury from September 2021 to October 2022 and treated with the new decannulation procedure.
SABI patients in whom decannulation was attempted before implementation of the new procedure.
Patients with SABI and a tracheal tube in whom decannulation was attempted between July 2019 until December 2020 will serve as a historical control group.
Interventions
From the 1st of September 2021, the investigators started to perform decannulation earlier after admission to the Department of Brain Injury. Before attempting to decannulate a patient, several factors were considered and assessed by the patient's treating team: patient's level of consciousness, hemodynamical stability, need for and frequency of salivary aspiration, cough strength and respiration frequency. Patients could not be under treatment for pneumonia and simultaneously have respiratory instability at the time of decannulation.
Eligibility Criteria
All adult SABI patients ≥ 18 years with a tracheal tube at admission to the Department of Brain Injury from September 2021 to October 2022 and treated with the new decannulation procedure will be included. Patients with SABI and a tracheal tube in whom decannulation was attempted between July 2019 until December 2020 will serve as a historical control group.
You may qualify if:
- All severe acquired brain injury patients ≥ 18 years with a tracheal tube at admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Brain Injury, Rigshospitalet
Glostrup Municipality, 2600, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Head, MD, PhD
Study Record Dates
First Submitted
November 17, 2023
First Posted
December 12, 2023
Study Start
July 1, 2023
Primary Completion
January 1, 2024
Study Completion
April 1, 2024
Last Updated
December 12, 2023
Record last verified: 2023-12